BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7765069)

  • 1. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy.
    Taylor-Papadimitriou J; Epenetos AA
    Trends Biotechnol; 1994 Jun; 12(6):227-33. PubMed ID: 7765069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucins: structure, function, and associations with malignancy.
    Devine PL; McKenzie IF
    Bioessays; 1992 Sep; 14(9):619-25. PubMed ID: 1365918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.
    Dong Y; Walsh MD; Cummings MC; Wright RG; Khoo SK; Parsons PG; McGuckin MA
    J Pathol; 1997 Nov; 183(3):311-7. PubMed ID: 9422987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
    Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
    Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma.
    Cloosen S; Gratama J; van Leeuwen EB; Senden-Gijsbers BL; Oving EB; von Mensdorff-Pouilly S; Tarp MA; Mandel U; Clausen H; Germeraad WT; Bos GM
    Br J Haematol; 2006 Nov; 135(4):513-6. PubMed ID: 17010104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of tandem repeat number to the O-glycosylation of mucins.
    Silverman HS; Sutton-Smith M; McDermott K; Heal P; Leir SH; Morris HR; Hollingsworth MA; Dell A; Harris A
    Glycobiology; 2003 Apr; 13(4):265-77. PubMed ID: 12626424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.
    Ho JJ; Cheng S; Kim YS
    Biochem Biophys Res Commun; 1995 May; 210(3):866-73. PubMed ID: 7539263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
    Bresalier RS; Byrd JC; Wang L; Raz A
    Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
    Ho SB; Ewing SL; Montgomery CK; Kim YS
    Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
    Burchell J; Taylor-Papadimitriou J
    Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA.
    Jerome KR; Bu D; Finn OJ
    Cancer Res; 1992 Nov; 52(21):5985-90. PubMed ID: 1382849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo glycosylation of mucin tandem repeats.
    Silverman HS; Parry S; Sutton-Smith M; Burdick MD; McDermott K; Reid CJ; Batra SK; Morris HR; Hollingsworth MA; Dell A; Harris A
    Glycobiology; 2001 Jun; 11(6):459-71. PubMed ID: 11445551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer associated mucin: a review.
    Segal-Eiras A; Croce MV
    Allergol Immunopathol (Madr); 1997; 25(4):176-81. PubMed ID: 9269507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of mucin gene expression in normal and neoplastic lung tissues.
    Seregni E; Botti C; Lombardo C; Cantoni A; Bogni A; Cataldo I; Bombardieri E
    Anticancer Res; 1996; 16(4B):2209-13. PubMed ID: 8694545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice.
    Peat N; Gendler SJ; Lalani N; Duhig T; Taylor-Papadimitriou J
    Cancer Res; 1992 Apr; 52(7):1954-60. PubMed ID: 1372533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive liquid chromatography-electrospray mass spectrometry allows for the analysis of the O-glycosylation of immunoprecipitated proteins from cells or tissues: application to MUC1 glycosylation in cancer.
    Bäckström M; Thomsson KA; Karlsson H; Hansson GC
    J Proteome Res; 2009 Feb; 8(2):538-45. PubMed ID: 19072658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate antigens on cancer-associated mucin-like molecules.
    Ho SB; Kim YS
    Semin Cancer Biol; 1991 Dec; 2(6):389-400. PubMed ID: 1725730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.